Monopar Therapeutics Inc (MNPR)

08:36 AM

MNPR: Barclays Initiates Coverage with Overweight Rating | MNPR Stock News - GuruFocus

08:36 AM

08:25 AM

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

08:25 AM

08:09 AM

Is Monopar Therapeutics Inc. forming a reversal patternJuly 2025 Summary & Weekly Stock Performance Updates - newser.com

08:09 AM

05:54 AM

Monopar Therapeutics initiated with an Overweight at Barclays - TipRanks

05:54 AM

Oct 12, 2025

Is Monopar Therapeutics Inc. stock safe for conservative investors2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com

Oct 12, 2025

Oct 12, 2025

Real time social sentiment graph for Monopar Therapeutics Inc.Weekly Trade Recap & Free Community Consensus Stock Picks - newser.com

Oct 12, 2025

Oct 12, 2025

Monopar Therapeutics (NASDAQ:MNPR) Raised to Strong-Buy at Jones Trading - Defense World

Oct 12, 2025

Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Stock Price Down 12.3%Here's What Happened - MarketBeat

Oct 11, 2025

Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Upgraded to "Strong-Buy" at Jones Trading - MarketBeat

Oct 11, 2025

Oct 10, 2025

Monopar Therapeutics: A Healthy Dose Of Skepticism Warranted (NASDAQ:MNPR) - Seeking Alpha

Oct 10, 2025

Oct 10, 2025

Institutional scanner results for Monopar Therapeutics Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Monopar Therapeutics' (MNPR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Monopar Therapeutics Inc.: Promising Prospects with ALXN1840 Acquisition and Wilson’s Disease Market Potential - TipRanks

Oct 10, 2025

Oct 10, 2025

What analysts say about Monopar Therapeutics Inc stockProtective Put Strategies & Low Risk Investment Trading - earlytimes.in

Oct 10, 2025

Oct 09, 2025

How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

Oct 09, 2025

Oct 06, 2025

Raymond James Maintains Monopar Therapeutics (MNPR) Strong Buy Recommendation - Nasdaq

Oct 06, 2025

Oct 06, 2025

MNPR: Raymond James Raises Price Target to $142, Maintains Stron - GuruFocus

Oct 06, 2025

Oct 06, 2025

Monopar Therapeutics (NASDAQ:MNPR) Hits New 1-Year HighTime to Buy? - MarketBeat

Oct 06, 2025

Oct 06, 2025

How to integrate Monopar Therapeutics Inc. into portfolio analysis toolsWatch List & Fast Gaining Stock Strategy Reports - newser.com

Oct 06, 2025

Oct 06, 2025

Historical volatility pattern of Monopar Therapeutics Inc. visualizedTrade Entry Summary & Entry Point Strategy Guides - newser.com

Oct 06, 2025

Oct 06, 2025

Will Monopar Therapeutics Inc. (1IY0) stock beat Nasdaq index returnsTrade Risk Summary & Long-Term Safe Investment Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Will Monopar Therapeutics Inc. stock recover faster than peersMarket Performance Report & Weekly Hot Stock Watchlists - newser.com

Oct 06, 2025

Oct 06, 2025

Risk adjusted return profile for Monopar Therapeutics Inc. analyzedJuly 2025 Big Picture & High Return Stock Watch Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Can trapped investors hope for a rebound in Monopar Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Is Monopar Therapeutics Inc. (1IY0) stock overpriced at current multiplesJuly 2025 Recap & Entry Point Confirmation Signals - newser.com

Oct 05, 2025

Oct 05, 2025

Using portfolio simulators with Monopar Therapeutics Inc. includedJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Analyzing Monopar Therapeutics Inc. with risk reward ratio chartsGlobal Markets & Community Shared Stock Ideas - newser.com

Oct 03, 2025

Oct 03, 2025

Can volume confirm reversal in Monopar Therapeutics Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - newser.com

Oct 03, 2025

Oct 02, 2025

Oppenheimer Maintains Monopar Therapeutics (MNPR) Outperform Recommendation - Nasdaq

Oct 02, 2025

Oct 02, 2025

Oppenheimer Raises Price Target for Monopar Therapeutics (MNPR) - GuruFocus

Oct 02, 2025

Oct 02, 2025

Oppenheimer Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $115 - 富途牛牛

Oct 02, 2025

Oct 02, 2025

BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $104 - 富途牛牛

Oct 02, 2025

Oct 02, 2025

HC Wainwright Has Optimistic Outlook of MNPR FY2027 Earnings - Defense World

Oct 02, 2025

Oct 01, 2025

What is HC Wainwright's Estimate for MNPR FY2027 Earnings? - MarketBeat

Oct 01, 2025